Is Jazz Pharmaceuticals a good place to work?

Is Jazz Pharmaceuticals a good place to work?

It’s difficult to cover everything I enjoy about this company. Clear, constant communication to all employees, great benefits and pay, very flexible in working with you and a work-life balance, extremely knowledgeable and passionate colleagues, influential.

What is Jazz Pharmaceuticals known for?

Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully.

Who owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals

Type Public company
Key people Bruce C. Cozadd (Chairman & CEO)
Products Pharmaceutical drugs
Brands Xyrem Erwinaze Defitelio FazaClo FazaClo HD Luvox CR Prialt Vyxeos
Revenue US$1.618 billion (2017)

Where is Jazz Pharmaceuticals located?

Dublin, Ireland
Our corporate headquarters are located in Dublin, Ireland. In the North America, we have offices in Palo Alto and Carlsbad, California; Philadelphia, Pennsylvania; Vancouver, British Columbia; and Mississauga, Ontario.

What kind of company is Jazz Pharmaceuticals?

biopharmaceutical company
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families.

Is Jazz Pharmaceuticals a buy?

Jazz Pharmaceuticals PLC (JAZZ) stock has gained 19.63% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. This means analysts expect the stock to increase 37.52% over the next 12 months. JAZZ’s rank also includes a short-term technical score of 74.

What is Biopharm?

Biopharmaceuticals, known colloquially as bio-pharma, are the point at which biotechnology and pharmaceutical manufacturing meet. Bio-pharma is the application of living organisms or extractions, by-products or components of living organisms, to prevent, relieve, or treat diseases.

Did Jazz Pharma buy pharma?

DUBLIN , May 5, 2021 /PRNewswire/ — Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”), a leader in the science, development and commercialization of cannabinoid-based prescription medicines.

When did jazz pharmaceuticals go public?

June 1, 2007
Jazz Pharmaceuticals’ common stock is expected to begin trading on the NASDAQ Global Market under the trading symbol “JAZZ” on Friday, June 1, 2007.

Who is the CEO of Jazz Pharmaceuticals?

Bruce C Cozadd
Jazz Pharmaceuticals/CEO

Does Jazz pharmaceutical pay dividends?

No, Jazz Pharmaceuticals plc does not pay a dividend and therefore does not have such a program.

Where is Jazz Pharmaceuticals Manufacturing facility in Ireland?

The Jazz Pharmaceuticals Ireland Manufacturing and Development facility is located in Monksland, west of Athlone Town, in an area zoned for industrial development by Roscommon County Council, just over 70 miles from our Dublin headquarters.

What is the purpose of Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases—often with limited or no therapeutic options.

Where can I find job listings for Jazz Pharmaceuticals?

All open opportunities at Jazz are posted on the Careers site, https://careers.jazzpharma.com/global/en. Any questions about job listings can be directed to [email protected].

When did the jazz plant open in Ireland?

Opened in 2016, it was the first directly owned and operated Jazz facility capable of developing, manufacturing and packaging drug products. The site is approved by multiple regulatory authorities and manufactures products for clinical and commercial use.

Begin typing your search term above and press enter to search. Press ESC to cancel.

Back To Top